AMR is widely recognised as a major threat to global health. Bacterial AMR was associated with an estimated 4.71 million deaths in 2021, of which 1.14 million were directly attributable to it. As multidrug-resistant pathogens continue to challenge healthcare systems worldwide, we can look to an infectious disease that we have made progress in– tuberculosis (TB). TB management has faced many of the same obstacles that we see in the wider AMR landscape today: delayed diagnosis
